Skip to main content

Advertisement

Open Peer Review Reports for: FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragm in ® a dded to standard t herapy i n patients with lung c ancer

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
9 Apr 2009 Submitted Original manuscript
3 Jun 2009 Reviewed Reviewer Report - Mario Furlanut
5 Jun 2009 Reviewed Reviewer Report - Andrew Vickers
28 Jul 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 2
28 Jul 2009 Submitted Manuscript version 2
5 Aug 2009 Reviewed Reviewer Report - Andrew Vickers
15 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 3
15 Sep 2009 Submitted Manuscript version 3
15 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 4
15 Sep 2009 Submitted Manuscript version 4
24 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 5
24 Sep 2009 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
29 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 7
29 Sep 2009 Submitted Manuscript version 7
Publishing
6 Oct 2009 Editorially accepted
6 Oct 2009 Article published 10.1186/1471-2407-9-355

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement